Quick Answer
TANDEM DIABETES CARE INC reported Net Income Loss of -$204.71 million for the year ending 2025.
- TANDEM DIABETES CARE INC showed a decrease of -113.2% in Net Income Loss from 2024 to 2025.
- This data is from TANDEM DIABETES CARE INC's annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), TANDEM DIABETES CARE INC's Net Income Loss has declined by 520.1%.
- Historical annual values: Fiscal year 2025: -$204.71 million | Fiscal year 2024: -$96.03 million | Fiscal year 2023: -$222.61 million | Fiscal year 2022: -$94.59 million | Fiscal year 2021: $15.57 million | Fiscal year 2020: -$34.38 million | Fiscal year 2019: -$24.75 million | Fiscal year 2018: -$122.61 million | Fiscal year 2017: -$73.03 million | Fiscal year 2016: -$83.45 million | Fiscal year 2015: -$72.42 million | Fiscal year 2014: -$79.52 million | Fiscal year 2013: -$63.14 million | Fiscal year 2012: -$33.02 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: